melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling
Melior Discovery
home
Our Services
High Throughput In Vivo Pharmacology:
Discovery Services:
Our Technology
 
Click here to download the Melior Brochure        

Click here to download the Melior Models list           

theraTRACE

Melior Pharmaceuticals

 melior melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling

Melior Discovery scientific advisors

 
   

April 2009 Melior Discovery Newsletter

Featured Article:
Is There a Shortcut to Drug Development Success?

Melior Discovery Inc. is dedicated to uncovering new therapeutic applications for partners’ existing drugs or drug candidates. By utilizing the unique and highly efficient theraTRACE® indications discovery platform, Melior can systematically evaluate a single compound in multiple in vivo models, thereby identifying potential utility in a broad range of major therapeutic areas.

melior

Other articles:
» Pioneering High Throughput Pharmacology as a Uniquely Productive Drug Discovery Strategy
» Melior Announces the Availability of an Exclusive Model for Alzheimer’s Disease
» In Vivo PK and Bioanalytical Capabilities


Back to top of page